Logo image of XPEV

XPENG INC - ADR (XPEV) Stock Fundamental Analysis

NYSE:XPEV - New York Stock Exchange, Inc. - US98422D1054 - ADR - Currency: USD

19.87  -0.38 (-1.88%)

Fundamental Rating

3

XPEV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Automobiles industry. Both the profitability and financial health of XPEV have multiple concerns. XPEV is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XPEV has reported negative net income.
In the past year XPEV has reported a negative cash flow from operations.
In the past 5 years XPEV always reported negative net income.
In the past 5 years XPEV reported 4 times negative operating cash flow.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -2B -4B -6B -8B -10B

1.2 Ratios

XPEV has a Return On Assets (-10.52%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -23.19%, XPEV is in line with its industry, outperforming 55.26% of the companies in the same industry.
Industry RankSector Rank
ROA -10.52%
ROE -23.19%
ROIC N/A
ROA(3y)-10.84%
ROA(5y)-18.73%
ROE(3y)-21.62%
ROE(5y)-48.25%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

With a Gross Margin value of 12.27%, XPEV perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
In the last couple of years the Gross Margin of XPEV has declined.
XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.51%
GM growth 5YN/A
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPEV has been increased compared to 1 year ago.
The number of shares outstanding for XPEV has been increased compared to 5 years ago.
XPEV has a worse debt/assets ratio than last year.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

2.2 Solvency

XPEV has an Altman-Z score of 1.76. This is a bad value and indicates that XPEV is not financially healthy and even has some risk of bankruptcy.
XPEV has a Altman-Z score of 1.76. This is in the better half of the industry: XPEV outperforms 76.32% of its industry peers.
XPEV has a Debt/Equity ratio of 0.59. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, XPEV perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACCN/A
WACC13.72%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10B -10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.50 indicates that XPEV should not have too much problems paying its short term obligations.
XPEV has a Current ratio (1.50) which is comparable to the rest of the industry.
A Quick Ratio of 1.31 indicates that XPEV should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.31, XPEV is doing good in the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.31
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.91% over the past year.
XPEV shows a strong growth in Revenue. In the last year, the Revenue has grown by 66.09%.
XPEV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 398.15% yearly.
EPS 1Y (TTM)52.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.68%
Revenue 1Y (TTM)66.09%
Revenue growth 3Y73.79%
Revenue growth 5Y398.15%
Sales Q2Q%18.43%

3.2 Future

Based on estimates for the next years, XPEV will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.52% on average per year.
The Revenue is expected to grow by 25.52% on average over the next years. This is a very strong growth
EPS Next Y54.48%
EPS Next 2Y32.87%
EPS Next 3Y27.06%
EPS Next 5Y18.52%
Revenue Next Year29.89%
Revenue Next 2Y50.66%
Revenue Next 3Y44.47%
Revenue Next 5Y25.52%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50B 100B 150B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XPEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XPEV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

XPEV's earnings are expected to grow with 27.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.87%
EPS Next 3Y27.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPEV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPENG INC - ADR

NYSE:XPEV (3/4/2025, 9:31:09 AM)

19.87

-0.38 (-1.88%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-19 2024-11-19/bmo
Earnings (Next)03-10 2025-03-10/amc
Inst Owners14.49%
Inst Owner Change26.91%
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap18.84B
Analysts76.25
Price Target15.24 (-23.3%)
Short Float %8.96%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.32%
Min EPS beat(2)-6.07%
Max EPS beat(2)26.7%
EPS beat(4)2
Avg EPS beat(4)15.79%
Min EPS beat(4)-12.26%
Max EPS beat(4)54.79%
EPS beat(8)2
Avg EPS beat(8)-3.55%
EPS beat(12)4
Avg EPS beat(12)-7.43%
EPS beat(16)5
Avg EPS beat(16)-11.06%
Revenue beat(2)0
Avg Revenue beat(2)-7.22%
Min Revenue beat(2)-11.83%
Max Revenue beat(2)-2.61%
Revenue beat(4)0
Avg Revenue beat(4)-5.27%
Min Revenue beat(4)-11.83%
Max Revenue beat(4)-2.17%
Revenue beat(8)0
Avg Revenue beat(8)-8.35%
Revenue beat(12)3
Avg Revenue beat(12)-3.81%
Revenue beat(16)7
Avg Revenue beat(16)-1.79%
PT rev (1m)1.47%
PT rev (3m)13.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.64%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.79
P/FCF N/A
P/OCF N/A
P/B 4.04
P/tB 4.69
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS5.24
BVpS4.92
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.52%
ROE -23.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.27%
FCFM N/A
ROA(3y)-10.84%
ROA(5y)-18.73%
ROE(3y)-21.62%
ROE(5y)-48.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.51%
GM growth 5YN/A
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.67%
Cap/Sales 5.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.31
Altman-Z 1.76
F-Score4
WACC13.72%
ROIC/WACCN/A
Cap/Depr(3y)428.76%
Cap/Depr(5y)615.79%
Cap/Sales(3y)15.18%
Cap/Sales(5y)30.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.68%
EPS Next Y54.48%
EPS Next 2Y32.87%
EPS Next 3Y27.06%
EPS Next 5Y18.52%
Revenue 1Y (TTM)66.09%
Revenue growth 3Y73.79%
Revenue growth 5Y398.15%
Sales Q2Q%18.43%
Revenue Next Year29.89%
Revenue Next 2Y50.66%
Revenue Next 3Y44.47%
Revenue Next 5Y25.52%
EBIT growth 1Y34.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.94%
EBIT Next 3Y27.75%
EBIT Next 5Y23.89%
FCF growth 1Y89.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.62%
OCF growth 3YN/A
OCF growth 5YN/A